期刊文献+

淀粉样蛋白A在骨关节炎患者血清中的表达及诊断价值 被引量:2

Expression and diagnostic value of serum amyloid A in patients with osteoarthritis
下载PDF
导出
摘要 目的分析淀粉样蛋白A(SAA)在骨关节炎(OA)患者血清中的表达并探讨其诊断价值。方法收集2018年7月1日至2019年7月1日在浙江省台州医院首诊为OA61例、系统性红斑狼疮(SLE)83例、类风湿关节炎(RA)131例患者及体检健康人群139例(健康对照组)的临床信息及实验室检测数据。采用Kruskal-Wallis检验比较OA、SLE、RA患者及健康对照组血清SAA水平的差异,采用Spearman相关分析检测SAA与OA、SLE及RA的相关性,ROC曲线分析SAA对OA的诊断价值。结果SAA在OA患者中的表达显著高于SLE、RA患者及健康对照组,SAA与OA呈正相关(r=0.472,P<0.001)。以健康对照组为对照,SAA诊断OA的AUC为0.887(95%CI:0.829,0.946),最佳cut-off值为9 mg/L,灵敏度为0.820,特异度为0.877,阳性预测值为74.6%,阴性预测值为91.7%,以SLE和RA患者为对照,SAA诊断OA的AUC为0.748(95%CI:0.676,0.820),最佳cut-off值为37 mg/L,灵敏度为0.607,特异度为0.808,阳性预测值为47.4%,阴性预测值为87.8%。结论OA患者血清中SAA表达上调,且SAA与OA呈正相关,SAA可作为OA有效筛查和鉴别诊断的实验室指标。 Objective To investigate the expression and diagnostic value of serum amyloid A(SAA)in patients with osteoarthritis(OA).Methods Clinical information and laboratory test data of patients with OA,systemic lupus erythematosus(SLE),rheumatoid arthritis(RA)and healthy subjects were collected from Taizhou Hospital.The difference of SAA in OA,SLE,RA patients and healthy subjects was detected by Kruskal-Wallis test,and the correlation of SAA with OA,SLE,RA was examined by bivariate correlation analysis,and the diagnostic value of SAA in OA was analyzed by ROC curve.Results SAA expression in OA was significantly higher than that in SLE,RA patients and healthy controls.SAA was positively correlated with OA(r=0.472,P<0.001).With healthy subjects as controls,the area under the curve(AUC)of SAA for diagnosis of OA was 0.887(0.829,0.946);taking 9 mg/L as cut-off value,the sensitivity was 0.820,the specificity was 0.877,the positive predictive value was 74.6%,and the negative predictive value was 91.7%.With SLE and RA as the controls,the AUC of SAA for diagnosis of OA was 0.748(0.676,0.820);taking 37 mg/L as cut-off value,the sensitivity was 0.607,the specificity was 0.808,the positive predictive value was 47.4%,and the negative predictive value was 87.8%.Conclusion SAA expression in serum of patients with OA is up-regulated,and SAA is positively correlated with OA disease,SAA can be used as an effective laboratory indicator for OA screening and differential diagnosis.
作者 朱小丽 胡金喜 金敏雅 ZHU Xiaoli;HU Jinxi;JIN Minya(Department of Clinical Laboratory,Taizhou Hospital,Taizhou 317000,China)
出处 《浙江医学》 CAS 2020年第16期1729-1732,1741,共5页 Zhejiang Medical Journal
基金 台州市科技计划B类(1702KY06,1702KY25) 恩泽医疗中心(集团)科学研究基金(15EZA3)。
关键词 淀粉样蛋白A 骨关节炎 表达 诊断价值 Serum amyloid A Osteoarthritis Expression Diagnostic value
  • 相关文献

参考文献2

二级参考文献34

  • 1Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
  • 2Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34.
  • 3Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546.
  • 4Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540.
  • 5Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179.
  • 6Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388.
  • 7Zhang W, Doherty M. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med, 2006, 40: 664-669.
  • 8Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2000, 59: 936-944.
  • 9Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2005, 64: 669-681.
  • 10Chevalier X, Marre JP, de Butler J, et al. Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations. Clin Exp Rheumatol, 2004, 22: 205-212.

共引文献1972

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部